MedTrace Logo

Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients

NCT01865890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-05-31

No results posted yet for this study

Summary

The investigators are trying to find out if Clopidogrel (Plavix) is as effective in hemodialysis patients as in patients not hemodialysed.

Conditions

Sponsors & Collaborators

  • Staten Island University Hospital

    collaborator OTHER

  • Northwell Health

    lead OTHER

Principal Investigators

  • Suzanne El-Sayegh, MD · Staten Island University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01865890 on ClinicalTrials.gov